Understanding how a protein called MGP affects fat tissue scarring
Mechanism of Matrix Gla Protein (MGP); Adipose Fibrosis
This project explores how a protein called MGP helps prevent scarring in fat tissue, which can lead to health problems like obesity and diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11141840 on NIH RePORTER |
What this research studies
Adipose fibrosis, or scarring in fat tissue, can cause issues in conditions like obesity and diabetes. This scarring happens when certain cells become overactive and create too much altered tissue. We are looking into the role of a protein called Matrix Gla Protein (MGP), which seems to stop this scarring process. By studying mice that lack MGP and analyzing cells at a very detailed level, we hope to uncover how MGP protects fat tissue from becoming fibrotic. This work aims to clarify the cellular changes that lead to fat tissue dysfunction.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation at this stage, but future studies based on these findings might seek individuals with obesity, diabetes, or related inflammatory conditions.
Not a fit: Patients not experiencing adipose fibrosis or related metabolic conditions would likely not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent or treat fat tissue scarring, potentially improving health outcomes for people with obesity, diabetes, and inflammatory conditions.
How similar studies have performed: While the role of MGP as an inhibitor of BMPs is known, its specific mechanism in adipose fibrosis and the detailed cellular pathways explored here represent a novel and untested approach.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Bostrom, Kristina I — University of California Los Angeles
- Study coordinator: Bostrom, Kristina I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.